Novo to buy Akero for $5.2 billion, to pocket trial liver disease drug
Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease,.
Bharti Rana Jayshankar – Founder
She brings in more than 30 years of experience in content building, architecture, writing, editing and storytelling. Ms Jayshankar has worked in the Economic Times daily, IBT Times, Investopedia and more than a dozen content firms as a content strategist and planner.
Jay Shankar – Co-founder
He has almost three decades of experience in journalism. He has worked with national dailies such as ET, Indian Express, The Pioneer, The Hindu, Agence France Presse and Bloomberg.
Novo Nordisk will acquire US-based Akero Therapeutics, Inc. for $5.2 billion to pocket an experimental drug in end-stage trials to treat liver disease,.
Zenas BioPharma, Inc. and China’s InnoCare Pharma Limited have inked a $2 billion licensing deal that grants the US-based Zenas global rights to.
University of Cambridge scientists have developed a first-time imaging technique that helps visualise and quantify the early triggers of Parkinson’s — the world’s.
The US regulator has declined to approve an experimental pediatric drug of Fortress Biotech Inc., an American biotechnology company, due to certain production.
Pfizer Inc., a US pharmaceutical company founded in 1849, has signed an agreement with the Trump administration to lower prices of prescription medicines.
HQ Team September 30, 2025: Scientists from the Perelman School of Medicine at the University of Pennsylvania and Cincinnati Children’s have developed an.
HQ Team September 30, 2025: Until recently, scientists mainly believed that Metformin, used to help control type 2 diabetes, worked by reducing glucose.
HQ Team September 27, 2025:Chronic disregards and systematic underinvestment has left women largely out of healthcare through the ages. What is more worrying.
HQ Team September 26, 2025: Autism has long occupied a complex and often contentious place in medical and cultural history. Since it was.
HQ Team September 25, 2025: Scientists in the United Kingdom have found a novel gene therapy known as AMT-130 that has slowed the.
We use cookies to improve your experience on our site. By using our site, you consent to cookies.
Manage your cookie preferences below:
Essential cookies enable basic functions and are necessary for the proper function of the website.
Statistics cookies collect information anonymously. This information helps us understand how visitors use our website.
Google Analytics is a powerful tool that tracks and analyzes website traffic for informed marketing decisions.
Service URL: policies.google.com